Memorial Sloan-Kettering Cancer Institute — New York, New York

Memorial Sloan-Kettering Cancer Institute is a clinical research site located in New York, New York, United States 10174.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan-Kettering Cancer Institute has participated in 3 clinical trials.

Therapeutic areas: Glioma, Low-grade Glioma, Astrocytoma.

Sponsors: Dana-Farber Cancer Institute, Cytheris, Inc., AEterna Zentaris.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan-Kettering Cancer Institute?

Memorial Sloan-Kettering Cancer Institute has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan-Kettering Cancer Institute conducted?

Memorial Sloan-Kettering Cancer Institute has 3 clinical trials on record. Their work covers Glioma, Low-grade Glioma, Astrocytoma.

Is Memorial Sloan-Kettering Cancer Institute accredited by Crixeo Health?

Memorial Sloan-Kettering Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan-Kettering Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.